相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The current drug discovery landscape for trypanosomiasis and leishmaniasis: Challenges and strategies to identify drug targets
Fernando Altamura et al.
DRUG DEVELOPMENT RESEARCH (2022)
Cutaneous leishmaniasis of the face treated with imiquimod 3.75%
Ignasi Marti-Marti et al.
ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA (2021)
Efficacy and Safety of Paromomycin for Visceral Leishmaniasis: A Systematic Review
Pashupati Pokharel et al.
JOURNAL OF TROPICAL MEDICINE (2021)
Nano- and Microformulations to Advance Therapies for Visceral Leishmaniasis
Devika M. Varma et al.
ACS BIOMATERIALS SCIENCE & ENGINEERING (2021)
Antileishmanial activity of fullerol and its liposomal formulation in experimental models of visceral leishmaniasis
Guilherme S. Ramos et al.
BIOMEDICINE & PHARMACOTHERAPY (2021)
A novel delivery of curcumin by the efficient nanoliposomal approach against Leishmania major
Ali Fattahi Bafghi et al.
PREPARATIVE BIOCHEMISTRY & BIOTECHNOLOGY (2021)
Efficacy of imiquimod 5% cream as first-line management in cutaneous leishmaniasis caused by Leishmania mexicana
Gabriela Fuentes-Nava et al.
REVISTA DA SOCIEDADE BRASILEIRA DE MEDICINA TROPICAL (2021)
Nano-elastic liposomes as multidrug carrier of sodium stibogluconate and ketoconazole: A potential new approach for the topical treatment of cutaneous Leishmaniasis
M. Junaid Dar et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2020)
Therapeutic Efficacy of a Mixed Formulation of Conventional and PEGylated Liposomes Containing Meglumine Antimoniate, Combined with Allopurinol, in Dogs Naturally Infected with Leishmania infantum
Cristiano C. P. dos Santos et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2020)
Current status of tropical theileriosis in Northern Africa: A review of recent epidemiological investigations and implications for control
Mohamed Gharbi et al.
TRANSBOUNDARY AND EMERGING DISEASES (2020)
A natural cell-penetrating nanopeptide combined with pentavalent antimonial as experimental therapy against cutaneous leishmaniasis
Joao Rafael Valentim Silva et al.
EXPERIMENTAL PARASITOLOGY (2020)
Berberine-Loaded Liposomes for the Treatment of Leishmania infantum-Infected BALB/c Mice
Alba Calvo et al.
PHARMACEUTICS (2020)
Targeting intracellular Leishmania (L.) infantum with nitazoxanide entrapped into phosphatidylserine-nanoliposomes: An experimental study
Erika Gracielle Pinto et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2020)
Potential of Artesunate in the treatment of visceral leishmaniasis in dogs naturally infected by Leishmania infantum: Efficacy evidence from a randomized field trial
Hacene Medkour et al.
PLOS NEGLECTED TROPICAL DISEASES (2020)
The activity of encapsulated meglumine antimoniate in stearylamine-bearing liposomes against cutaneous leishmaniasis in BALB/c mice
Seyedeh Alia Moosavian et al.
EXPERIMENTAL PARASITOLOGY (2019)
A Pluronic® F127-based polymeric micelle system containing an antileishmanial molecule is immunotherapeutic and effective in the treatment against Leishmania amazonensis infection
Grasiele S. V. Tavares et al.
PARASITOLOGY INTERNATIONAL (2019)
PEGylation: a promising strategy to overcome challenges to cancer-targeted nanomedicines: a review of challenges to clinical transition and promising resolution
Zahid Hussain et al.
DRUG DELIVERY AND TRANSLATIONAL RESEARCH (2019)
Sertraline Delivered in Phosphatidylserine Liposomes Is Effective in an Experimental Model of Visceral Leishmaniasis
Maiara Maria Romanelli et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2019)
Antileishmanial Activity, Cytotoxicity and Mechanism of Action of Clioquinol Against Leishmania infantum and Leishmania amazonensis Species
Grasiele de Sousa Vieira Tavares et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2018)
Pharmacokinetic of meglumine antimoniate encapsulated in phosphatidylserine-liposomes in mice model: A candidate formulation for visceral leishmaniasis
Samanta Etel Treiger Borborema et al.
BIOMEDICINE & PHARMACOTHERAPY (2018)
Quinoxaline derivatives as potential antitrypanosomal and antileishmanial agents
Juliana Cogo et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2018)
Orally Bioavailable and Effective Buparvaquone Lipid-Based Nanomedicines for Visceral Leishmaniasis
Lindsay Smith et al.
MOLECULAR PHARMACEUTICS (2018)
The role of MPL and imiquimod adjuvants in enhancement of immune response and protection in BALB/c mice immunized with soluble Leishmania antigen (SLA) encapsulated in nanoliposome
Tara Emami et al.
ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY (2018)
Sodium stibogluconate loaded nano-deformable liposomes for topical treatment of leishmaniasis: macrophage as a target cell
M. Junaid Dar et al.
DRUG DELIVERY (2018)
Treatment outcomes of visceral leishmaniasis in Ethiopia from 2001 to 2017: a systematic review and meta-analysis
Eyob Alemayehu Gebreyohannes et al.
INFECTIOUS DISEASES OF POVERTY (2018)
Nanoliposomal artemisinin for the treatment of murine visceral leishmaniasis
Muzamil Y. Want et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2017)
Nanotechnological Strategies for Treatment of Leishmaniasis-A Review
Letcia de Almeida et al.
JOURNAL OF BIOMEDICAL NANOTECHNOLOGY (2017)
Global burden of cutaneous leishmaniasis
Chante Karimkhani et al.
LANCET INFECTIOUS DISEASES (2017)
Buparvaquone Nanostructured Lipid Carrier: Development of an Affordable Delivery System for the Treatment of Leishmaniases
Lis Marie Monteiro et al.
BIOMED RESEARCH INTERNATIONAL (2017)
Mixed Formulation of Conventional and Pegylated Meglumine Antimoniate-Containing Liposomes Reduces Inflammatory Process and Parasite Burden in Leishmania infantum-Infected BALB/c Mice
Levi Eduardo Soares Reis et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Meglumine antimoniate is more effective than sodium stibogluconate in the treatment of cutaneous leishmaniasis
Yavuz Yesilova et al.
JOURNAL OF DERMATOLOGICAL TREATMENT (2016)
Topical liposomal azithromycin in the treatment of acute cutaneous leishmaniasis
Omid Rajabi et al.
DERMATOLOGIC THERAPY (2016)
Liposomes containing an ASP49-phospholipase A2 from Bothrops jararacussu snake venom as experimental therapy against cutaneous leishmaniasis
Neuza B. de Barros et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2016)
Lipid-based nanoformulations of trifluralin analogs in the management of Leishmania infantum infections
Rui M. Lopes et al.
NANOMEDICINE (2016)
Hemisynthetic trifluralin analogues incorporated in liposomes for the treatment of leishmanial infections
Manuela Carvalheiro et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2015)
Cinnamic acid derived compounds loaded into liposomes: antileishmanial activity, production standardisation and characterisation
Thuanny Alexandra Campos Cury et al.
JOURNAL OF MICROENCAPSULATION (2015)
Topical Resiquimod Protects against Visceral Infection with Leishmania infantum chagasi in Mice
Noah Craft et al.
CLINICAL AND VACCINE IMMUNOLOGY (2014)
Mixed formulation of conventional and pegylated liposomes as a novel drug delivery strategy for improved treatment of visceral leishmaniasis
Erly G. Azevedo et al.
EXPERT OPINION ON DRUG DELIVERY (2014)
Clinical treatment of cutaneous leishmaniasis in dogs with furazolidone and domperidone
Stela Rechinelli Passos et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2014)
Targeted therapy using nanotechnology: focus on cancer
Vanna Sanna et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2014)
Liposomal resiquimod for the treatment of Leishmania donovani infection
Kevin J. Peine et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2014)
Association of water extract of green propolis and liposomal meglumine antimoniate in the treatment of experimental visceral leishmaniasis
Flavia M. Ferreira et al.
PARASITOLOGY RESEARCH (2014)
Liposomal formulation of amphotericin B for the treatment of mucosal leishmaniasis in HIV-negative patients
Carolina Rocio et al.
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE (2014)
Facial Structure Alterations and Abnormalities of the Paranasal Sinuses on Multidetector Computed Tomography Scans of Patients with Treated Mucosal Leishmaniasis
Raphael Abegao de Camargo et al.
PLOS NEGLECTED TROPICAL DISEASES (2014)
Risk Factors for Adverse Prognosis and Death in American Visceral Leishmaniasis: A Meta-analysis
Vinicius Silva Belo et al.
PLOS NEGLECTED TROPICAL DISEASES (2014)
Lethal action of the nitrothiazolyl-salicylamide derivative nitazoxanide via induction of oxidative stress in Leishmania (L.) infantum
Juliana Tonini Mesquita et al.
ACTA TROPICA (2013)
Development and Validation of an Analytical Method for Quantification of Arsenic and Antimony in Liposomes Using Inductively Coupled Plasma-Optical Emission Spectrometry
Priscila G. Reis et al.
JOURNAL OF AOAC INTERNATIONAL (2013)
Effectiveness of liposomal buparvaquone in an experimental hamster model of Leishmania (L.) infantum chagasi
Juliana Q. Reimao et al.
EXPERIMENTAL PARASITOLOGY (2012)
Leishmaniasis Worldwide and Global Estimates of Its Incidence
Jorge Alvar et al.
PLOS ONE (2012)
Short Report: Can We Use a Lower Dose of Liposomal Amphotericin B for the Treatment of Mucosal American Leishmaniasis?
Valdir S. Amato et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2011)
In Vitro and In Vivo Studies of the Utility of Dimethyl and Diethyl Carbaporphyrin Ketals in Treatment of Cutaneous Leishmaniasis
Viviana M. Taylor et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Uptake and antileishmanial activity of meglumine antimoniate-containing liposomes in Leishmania (Leishmania) major-infected macrophages
Samanta Etel Treiger Borborema et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2011)
Visceral leishmaniasis: elimination with existing interventions
Greg Matlashewski et al.
LANCET INFECTIOUS DISEASES (2011)
Therapy with Sodium Stibogluconate in Stearylamine-Bearing Liposomes Confers Cure against SSG-Resistant Leishmania donovani in BALB/c Mice
Jayeeta Roychoudhury et al.
PLOS ONE (2011)
Leishmania (Viannia) braziliensis identification by PCR in the state of Para, Brazil
H. A. Bacha et al.
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE (2011)
Mucosal Leishmaniasis and Abnormalities on Computed Tomographic Scans of Paranasal Sinuses
Raphael A. Camargo et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2010)
Therapeutic evaluation of free and liposome-loaded furazolidone in experimental visceral leishmaniasis
Andre Gustavo Tempone et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2010)
Efficacy of artemisinin in experimental visceral leishmaniasis
Rupashree Sen et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2010)
Topical delivery and in vivo antileishmanial activity of paromomycin-loaded liposomes for treatment of cutaneous leishmaniasis
Guilherme Carneiro et al.
JOURNAL OF LIPOSOME RESEARCH (2010)
In vitro and in vivo antileishmanial efficacy of nitazoxanide against Leishmania donovani
Ruiyan Zhang et al.
PARASITOLOGY RESEARCH (2010)
Furazolidone is a selective in vitro candidate against Leishmania (L.) chagasi: an ultrastructural study
Juliana Quero Reimao et al.
PARASITOLOGY RESEARCH (2010)
Association of Acenaphthoporphyrins with Liposomes for the Photodynamic Treatment of Leishmaniasis
Daniel M. Gardner et al.
PHOTOCHEMISTRY AND PHOTOBIOLOGY (2010)
Liposomal Amphotericin B and Leishmaniasis: Dose and Response
Shyam Sundar et al.
JOURNAL OF GLOBAL INFECTIOUS DISEASES (2010)
Systematic review of New World cutaneous leishmaniasis: few points to be applied to Old World leishmaniasis
Felipe Francisco Tuon et al.
INTERNATIONAL JOURNAL OF DERMATOLOGY (2009)
Immunohistochemistry and polymerase chain reaction on paraffin-embedded material improve the diagnosis of cutaneous leishmaniasis in the Amazon region
Valdir Sabbaga Amato et al.
INTERNATIONAL JOURNAL OF DERMATOLOGY (2009)
Nitazoxanide, tizoxanide and a new analogue [4-nitro-N-(5-nitro-1,3-thiazol-2-yl)benzamide; NTB] inhibit the growth of kinetoplastid parasites (Trypanosoma cruzi and Leishmania mexicana) in vitro
Manuel Jesus Chan-Bacab et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2009)
Mucosal leishmaniasis: description of case management approaches and analysis of risk factors for treatment failure in a cohort of 140 patients in Brazil
V. S. Amato et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2009)
Mucosal leishmaniasis - Current scenario and prospects for treatment
Valdir Sabbaga Amato et al.
ACTA TROPICA (2008)
Treatment of New World cutaneous leishmaniasis - a systematic review with a meta-analysis
Felipe Francisco Tuon et al.
INTERNATIONAL JOURNAL OF DERMATOLOGY (2008)
Cutaneous leishmaniasis treated with azithromycin in a child
Philippe Minodier et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2008)
Failure of both azithromycin and antimony to treat cutaneous leishmaniasis in Manaus, AM, Brazil
Alan Cesar Teixeira et al.
REVISTA DO INSTITUTO DE MEDICINA TROPICAL DE SAO PAULO (2008)
NEGLECTED TROPICAL DISEASES: BEYOND THE WARS
Felipe Francisco Tuon et al.
REVISTA DO INSTITUTO DE MEDICINA TROPICAL DE SAO PAULO (2008)
Treatment of mucosal leishmaniasis in Latin america: Systematic review
Valdir Sabbaga Amato et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2007)
Treatment of mucosal leishmaniasis with a lipid formulation of amphotericin B
Valdir Sabbaga Amato et al.
CLINICAL INFECTIOUS DISEASES (2007)
Mucosal leishmaniasis and miltefosine
Felipe Francisco Tuon et al.
CLINICAL INFECTIOUS DISEASES (2007)
Improved targeting of antimony to the bone marrow of dogs using liposomes of reduced size
Dante A. Schettini et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2006)
A fatal case of mucocutaneous leishmaniasis after pentavalent antimonial use
MC Oliveira et al.
REVISTA DA SOCIEDADE BRASILEIRA DE MEDICINA TROPICAL (2005)
Harmine: Evaluation of its antileishmanial properties in various vesicular delivery systems
S Lala et al.
JOURNAL OF DRUG TARGETING (2004)
Dual action of antimonial drugs on thiol redox metabolism in the human pathogen Leishmania donovani
S Wyllie et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Macrophage specific drug delivery in experimental leishmaniasis
MK Basu et al.
CURRENT MOLECULAR MEDICINE (2004)
Combination therapy using sodium antimony gluconate in stearylamine-bearing liposomes against established and chronic Leishmania donovani infection in BALB/c mice
S Pal et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Synthesis, in vitro evaluation, and antileishmanial activity of water-soluble prodrugs of buparvaquone
A Mantyla et al.
JOURNAL OF MEDICINAL CHEMISTRY (2004)
Treatment of visceral leishmaniasis with sterically stabilized liposomes containing camptothecin
ME Proulx et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2001)
Therapeutic evaluation of free and liposome-encapsulated atovaquone in the treatment of murine leishmaniasis
E Cauchetier et al.
INTERNATIONAL JOURNAL FOR PARASITOLOGY (2000)
分享论文
